[ Price : $8.95]
Atara Biotherapeutics resubmits its BLA for Ebvallo (tabelecleucel or tab-cel), seeking approval for its use as monotherapy for tr...[ Price : $8.95]
FDA faces new uncertainty over its staffing and regulatory capacity following sweeping federal hiring restrictions and a pivotal S...[ Price : $8.95]
FDA approves a Bayer supplemental NDA to expand the labeling of Kerendia (finerenone) for reducing the risk of cardiovascular deat...[ Price : $8.95]
Edwards Lifesciences recalls its Optisite Arterial Cannula due to complaints received about its 3mm to 4mm section wire exposed/pr...[ Price : $8.95]
FDA leaders say that the agency is currently conducting benefit-risk modeling studies based on the evolving risk of Covid-19 sever...[ Price : $8.95]
FDA accepts for priority review a Merck supplemental BLA for Winrevair (sotatercept-csrk), seeking to update its label to reflect ...[ Price : $8.95]
FDA issues Capricor Therapeutics a complete response on its BLA for Deramiocel, a cell therapy candidate targeting cardiomyopathy ...[ Price : $8.95]
FDA clears an Intuitive 510(k) for its Vessel Sealer Curved advanced energy instrumentation for use with its multiport da Vinci sy...